NanoViricides Income Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2006
Selling, General & Admin	2.55	2.33	2.63	3.3	2.74	3.41	3.03	3.83	3.4	3.54	Upgrade
Research & Development	6.39	5.78	6.11	4.7	5.92	5.91	6.57	5.03	3.66	5.13	Upgrade
Operating Expenses	8.94	8.11	8.74	8	8.66	9.33	9.6	8.86	7.06	8.67	Upgrade
Operating Income	-8.94	-8.11	-8.74	-8	-8.66	-9.33	-9.6	-8.86	-7.06	-8.67	Upgrade
Interest Expense / Income	0	0.01	0.09	0.09	0	0.19	0.78	1.04	2.65	3.09	Upgrade
Other Expense / Income	-0.36	-0.01	-0.01	5.36	-0.24	-0.95	-0.08	0.82	-7.51	1.84	Upgrade
Pretax Income	-8.59	-8.11	-8.82	-13.45	-8.42	-8.56	-10.3	-10.72	-2.2	-13.6	Upgrade
Net Income	-8.59	-8.11	-8.82	-13.45	-8.42	-8.56	-10.3	-10.72	-2.2	-13.6	Upgrade
Shares Outstanding (Basic)	12	12	11	6	4	3	3	3	3	3	Upgrade
Shares Outstanding (Diluted)	12	12	11	6	4	3	3	3	3	3	Upgrade
Shares Change	0.79%	5.81%	94.08%	56.45%	10.60%	8.02%	4.22%	-2.62%	15.61%	7.60%	Upgrade
EPS (Basic)	-0.74	-0.70	-0.81	-2.39	-2.35	-2.64	-3.43	-3.80	-0.80	-5.40	Upgrade
EPS (Diluted)	-0.74	-0.70	-0.81	-2.39	-2.35	-2.64	-3.43	-3.80	-1.80	-5.40	Upgrade
Free Cash Flow	-5.82	-6.22	-8.45	-6.67	-6.88	-8.02	-8.06	-7.31	-12.97	-11.56	Upgrade
Free Cash Flow Per Share	-0.50	-0.54	-0.78	-1.19	-1.92	-2.47	-2.68	-2.53	-4.59	-4.51	Upgrade
EBITDA	-7.84	-7.38	-8.03	-12.65	-7.73	-7.7	-8.86	-9.02	0.75	-10.3	Upgrade
Depreciation & Amortization	0.75	0.72	0.7	0.7	0.7	0.68	0.66	0.66	0.3	0.21	Upgrade
EBIT	-8.59	-8.1	-8.74	-13.35	-8.42	-8.38	-9.52	-9.68	0.45	-10.51	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).